Free Amino Acid-based Formula to Treat Children Cow's Milk Protein Allergy
Tolerability to a New Free Amino Acid-based Formula in Children With Cow's Milk Protein Allergy
1 other identifier
interventional
15
0 countries
N/A
Brief Summary
It is a study to assess the tolerance to a new commercially available infant formula in children affected by Cow's Milk Allergy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Aug 2013
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 20, 2015
CompletedFirst Posted
Study publicly available on registry
August 31, 2015
CompletedAugust 31, 2015
August 1, 2015
1.5 years
August 20, 2015
August 28, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Study to assess the allergic symptoms, using a questionnaire.
The allergic symptoms were assessed every month, by using a questionnaire. The parents, during the medical appointment, answered "yes" or "no" according to the presented symptoms: cutaneous (atopic dermatitis and urticaria), gastrointestinal (vomiting, diarrhea constipation and bloody stools ) and respiratory. At the end of the study the children were evaluated if they tolerated the formula, it was observed by the symptoms remission.
5 months
Secondary Outcomes (3)
Weight assessment, using a digital infant scale
5 months
Height assessment, using an infantometer
5 months
Head circumference, using an infant tape measure
5 months
Study Arms (1)
Amix
EXPERIMENTALDietary supplement. The formula is based in free amino-acid to treat children with cow's milk allergy. The children should have a minimum consumption of 400 mL, daily.
Interventions
Eligibility Criteria
You may qualify if:
- Children with cow's milk allergy
You may not qualify if:
- Children without cow's milk allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Edetec Indústria Alimentícia S.A.lead
- Faculdade de Ciências Médicas de Minas Geraiscollaborator
- Federal University of Minas Geraiscollaborator
Related Publications (1)
Amari S, Shahrook S, Namba F, Ota E, Mori R. Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates. Cochrane Database Syst Rev. 2020 Oct 2;10(10):CD012273. doi: 10.1002/14651858.CD012273.pub2.
PMID: 33006765DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Wendel O Afonso, Master
UFMG
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2015
First Posted
August 31, 2015
Study Start
August 1, 2013
Primary Completion
February 1, 2015
Study Completion
June 1, 2015
Last Updated
August 31, 2015
Record last verified: 2015-08